Does LEMBOREXANT Cause Therapy non-responder? 12 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Therapy non-responder have been filed in association with LEMBOREXANT (DAYVIGO). This represents 1.2% of all adverse event reports for LEMBOREXANT.
12
Reports of Therapy non-responder with LEMBOREXANT
1.2%
of all LEMBOREXANT reports
0
Deaths
8
Hospitalizations
How Dangerous Is Therapy non-responder From LEMBOREXANT?
Of the 12 reports, 8 (66.7%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEMBOREXANT. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does LEMBOREXANT Cause?
Drug ineffective (225)
Suicide attempt (98)
Somnolence (90)
Suicidal ideation (86)
Sleep paralysis (80)
Condition aggravated (74)
Nightmare (71)
Altered state of consciousness (45)
Off label use (45)
Adverse drug reaction (44)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which LEMBOREXANT Alternatives Have Lower Therapy non-responder Risk?
LEMBOREXANT vs LENACAPAVIR
LEMBOREXANT vs LENALIDOMIDE
LEMBOREXANT vs LENIOLISIB
LEMBOREXANT vs LENOGRASTIM
LEMBOREXANT vs LENVATINIB